Exclusive

Publication

Byline

HekaBio teams up with Alfresa Holdings Corp accelerating access to innovative therapies in Japan

Singapore, June 17 -- HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading pharmaceutical wholesaler group in Japan. As part of this... Read More


Singapore designs new biomaterial to show how ageing in heart could be reversed

Singapore, June 16 -- A new lab-grown material has revealed that some of the effects of ageing in the heart may be slowed and even reversed. The discovery could open the door to therapies that rejuven... Read More


Australia develops AI tool to ensure colorectal cancer patients receive correct dose of chemotherapy

Singapore, June 16 -- University of Melbourne and Western Health researchers in Australia have developed a new artificial intelligence (AI) tool to prevent cancer patients from receiving incorrect dos... Read More


Samsung Biologics launches drug screening services, Samsung Organoids

Singapore, June 16 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced the launch ofSamsung Organoids- advanced drug screening s... Read More


SDP Japan raises $31 M to rollout advanced surgical care models

Singapore, June 16 -- Healthcare startup SDP Japan, Inc. hasraised approximatelyJPY 4.5 billion(equivalent to $31 million) through a Series D equity financing round, alongside secondary transaction, d... Read More


Gene Solutions, Shenzhen USK Bioscience to establish next-gen sequencing lab in Southern China

Singapore, June 16 -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co.(USKBio), a prominent innovator in molecular diagnostics, have entered a strategic pa... Read More


Bio International Convention 2025 opens in Boston, bringing together 20,000+ global biotech leaders

Singapore, June 16 -- TheBIO International Convention, the world's largest and most comprehensive event for the biotechnology industry, opens today in Boston. It will convene more than 20,000 biotech... Read More


Novatrials opens advanced Phase 1 clinical trials facility in Australia to meet global demand

Singapore, June 16 -- Novatrials, Australia's largest independently owned clinical trials site, is excited to announce its newly constructed Phase 1 facility, is now accepting study proposals. Renowne... Read More


Delayed care and lost clinical time call for accelerated AI adoption in APAC: Philips Survey

Singapore, June 13 -- Royal Philips, a global leader in health technology, has released the Asia Pacific (APAC) findings from its 10th annual Future Health Index (FHI) report, the largest global healt... Read More


Korea's Mezzion expands Udenafil pipeline to target multi-billion dollar kidney disease market

Singapore, June 13 -- South Korea-based Mezzion Pharma Co., a leader in rare disease therapeutics, has announced the expansion of its udenafil pipeline with the initiation of a pre-clinical study for ... Read More